Castration Levels of Testosterone

Oncology·MeSH: Prostatic Neoplasms

15 drugs in development·1 company·1 clinical trial

Drug Pipeline by Phase

Phase 3(4)

Drug	Company
her2-targeted therapy	GH Research PLC (GHRS)
hormone therapy	GH Research PLC (GHRS)
induction therapy	GH Research PLC (GHRS)
intravenous immunoglobulin therapy	GH Research PLC (GHRS)

Phase 2(7)

Drug	Company
abiraterone	GH Research PLC (GHRS)
androgen deprivation therapy	GH Research PLC (GHRS)
androgen receptor signal inhibitor	GH Research PLC (GHRS)
bridging therapy	GH Research PLC (GHRS)
chimeric antigen receptor t-cell therapy	GH Research PLC (GHRS)
conventional antihypertensive therapy	GH Research PLC (GHRS)
intensive antihypertensive therapy	GH Research PLC (GHRS)

Phase 1(2)

Drug	Company
group a standard-of-care backbone therapy	GH Research PLC (GHRS)
t-cell therapy	GH Research PLC (GHRS)

Phase 4(2)

Drug	Company
androgen-deprivation therapy	GH Research PLC (GHRS)
genotyping guided therapy for anti-platelet management	GH Research PLC (GHRS)

BioSniper tracks 15 drugs in development for Castration Levels of Testosterone across 1 company.

There are 1 clinical trial targeting Castration Levels of Testosterone tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.